Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-24 Ekman Lars Director Grant or award +3,300 17,745
2022-06-24 Ekman Lars Director Grant or award · Stock Option (Right to Buy) +6,245 6,245
2021-06-24 Ekman Lars Director Grant or award +2,145 14,445
2021-06-24 Ekman Lars Director Grant or award · Stock Option (Right to Buy) +4,125 4,125
2020-06-26 Ekman Lars Director Grant or award +2,550 12,300
2020-06-26 Ekman Lars Director Grant or award · Stock Option (Right to Buy) +4,250 4,250
2019-06-11 Ekman Lars Director Grant or award +3,000 9,750
2019-06-11 Ekman Lars Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-19 Ekman Lars Director Grant or award +3,000 6,750
2018-06-19 Ekman Lars Director Grant or award · Stock Option (Right to Buy) +5,000 5,000

Page 1 of 1 · 10 trades